ROL vs SLS · P/E 41, rev $1.99B vs $1.62B cap
Rollins Inc (ROL) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. SLS currently screens at market cap $1.62B.
Not investment advice. Open the ROL and SLS stock pages for the full models.
Not investment advice.